<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-title>BMC Genomics</journal-title><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2164-7-292</article-id><article-id pub-id-type="pmid">17109758</article-id><article-id pub-id-type="doi">10.1186/1471-2164-7-292</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Shin</surname><given-names>Ju-Mi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ju-mis@hanmail.net</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Yoo</surname><given-names>Kyong-Jai</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yukyongjai@sogang.ac.kr</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Kim</surname><given-names>Myung-Sun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lg-kms@hanmail.net</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kim</surname><given-names>Dongku</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dokukim@hanmail.net</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Baek</surname><given-names>Kwang-Hyun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>baek@cha.ac.kr</email></contrib></contrib-group><aff id="I1"><label>1</label>Graduate School of Life Science and Biotechnology, Cell and Gene Therapy Research Institute, Pochon CHA University, CHA General Hospital, Seoul 135-081, Korea</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>16</day><month>11</month><year>2006</year></pub-date><volume>7</volume><fpage>292</fpage><lpage>292</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2164/7/292"/><history><date date-type="received"><day>14</day><month>7</month><year>2006</year></date><date date-type="accepted"><day>16</day><month>11</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Shin et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Shin et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Shin Ju-Mi ju-mis@hanmail.net </dc:author><dc:title> Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Genomics 7(1): 292-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2164(2006)7:1&#x0003c;292&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2164</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Protein degradation by the ubiquitin system plays a crucial role in numerous cellular signaling pathways. Deubiquitination, a reversal of ubiquitination, has been recognized as an important regulatory step in the ubiquitin-dependent degradation pathway.</p></sec><sec><title>Results</title><p>While identifying putative ubiquitin specific protease (USP) enzymes that contain a conserved Asp (I) domain in humans, 4 <italic>USP17 </italic>subfamily members, highly homologous to DUB-3, have been found (USP17K, USP17L, USP17M, and USP17N), from human chorionic villi. Expression analysis showed that <italic>USP17 </italic>transcripts are highly expressed in the heart, liver, and pancreas and are expressed moderately in various human cancerous cell lines. Amino acid sequence analysis revealed that they contain the highly conserved Cys, His, and Asp domains which are responsible for the deubiquitinating activity. Biochemical enzyme assays indicated that they have deubiquitinating activity. Interestingly, the sequence analysis showed that these proteins, with exception of USP17N, contain the putative hyaluronan/RNA binding motifs, and cetylpyridinium chloride (CPC)-precipitation analysis confirmed the association between these proteins and intracellular hyaluronan and RNA.</p></sec><sec><title>Conclusion</title><p>Here, we report that the overexpression of these proteins, with exception of USP17N, leads to apoptosis, suggesting that the hyaluronan and RNA binding motifs in these enzymes play an important role in regulating signal transduction involved in cell death.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The post-translational modification by ubiquitin (Ub) plays an essential role for numerous cellular functions such as protein degradation, cell cycle control, transcriptional regulation, immune response, apoptosis, oncogenesis, pre-implantation, and intracellular signaling pathways [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Conjugation of ubiquitin to a target protein is achieved by the sequential enzymatic actions via ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3). A novel ubiquitination factor (E4) required for efficient multiubiquitination has been identified in yeast [<xref ref-type="bibr" rid="B7">7</xref>]. Proteins modified with a polyubiquitin chain are then unfolded and degraded by the 26S proteasome [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Deubiquitination, a removal of ubiquitin from ubiquitin-conjugated protein substrates, is mediated by a number of deubiquitinating enzymes. Most deubiquitinating (DUB) enzymes are cysteine proteases and consist of at least five families, the ubiquitin C-terminal hydrolases (UCH), the ubiquitin specific processing proteases (USP), Jab1/Pab1/MPN-domain-containing metallo-enzymes (JAMM), Otu-domain ubiquitin aldehyde-binding proteins (OTU), and Ataxin-3/Josephin [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. The USP family members vary in size and structural complexity, but all contain 6 characteristic conserved homology domains [<xref ref-type="bibr" rid="B5">5</xref>]. The UCH family members are relatively small molecules, which hydrolyze C-terminal amides and esters of ubiquitin [<xref ref-type="bibr" rid="B5">5</xref>]. The JAMM isopeptidases are known to deneddylate cullin (the CSN-5 subunit of the COP9/signalosome) and to release ubiquitin chains from proteins targeted for degradation (the RPN11 subunit of the proteasome) [<xref ref-type="bibr" rid="B11">11</xref>]. The members of OTU family have been reported as highly specific Ub isopeptidases, but they have no sequence homology to known DUBs [<xref ref-type="bibr" rid="B12">12</xref>]. Lastly, Ataxin-3 has a domain called the Josephin domain, cleaves ubiquitin-AMC, and binds to the DUB inhibitor ubiquitin aldehyde [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Hyaluronan is a kind of glycosaminoglycan, which is involved in the regulation of cell division [<xref ref-type="bibr" rid="B13">13</xref>], angiogenesis [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>], and cell motility [<xref ref-type="bibr" rid="B16">16</xref>]. Hyaluronan exists in extracellular and pericellular matrices and interacts with various kinds of proteins [<xref ref-type="bibr" rid="B17">17</xref>]. Recent reports showed the existence of a few intracellular hyaluronan binding proteins (IHABPs) and one of them, receptor form hyaluronan-mediated motility (RHAMM) binds intracellular hyaluronan and plays multiple roles including cell cycle arrest [<xref ref-type="bibr" rid="B18">18</xref>] and spindle pole stability [<xref ref-type="bibr" rid="B19">19</xref>].</p><p><italic>USP17 </italic>subfamily members have been previously identified [<xref ref-type="bibr" rid="B20">20</xref>] and one of them, <italic>DUB-3</italic>, has shown that the constitutive expression of <italic>DUB-3 </italic>blocks proliferation and can lead to apoptosis [<xref ref-type="bibr" rid="B21">21</xref>]. In this study, we have identified four novel members of <italic>USP17 </italic>subfamily which encode a deubiquitinating enzyme, from human chorionic villi tissues. Our study demonstrates for the first time that USP17 subfamily members of the DUB enzyme regulate apoptosis and cell death of cancerous cells and contain putative hyaluronan and RNA binding domains.</p></sec><sec><title>Results</title><sec><title>Cloning of <italic>USP17 </italic>subfamily members in human chorionic villi and embryonic carcinoma cell lines</title><p>To identify putative deubiquitinating enzymes that contain a conserved Asp (I) domain in humans, the GenBank database was accessed and searched using the BLAST algorithm at the NCBI, as described previously [<xref ref-type="bibr" rid="B22">22</xref>]. In this study, we obtained multiple cDNAs including <italic>DUB-3 </italic>[<xref ref-type="bibr" rid="B21">21</xref>] and <italic>USP17 </italic>[<xref ref-type="bibr" rid="B23">23</xref>] from human chorionic villi tissues and various cancer cell lines by RT-PCR. We performed RT-PCR, sequenced PCR products three times independently in order to exclude the possibility of PCR errors, and classified the genes as <italic>USP17 </italic>subfamily members (<italic>USP17K</italic>, <italic>USP17L</italic>, <italic>USP17M</italic>, and <italic>USP17N</italic>) due to the high homology to known sequences [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. To characterize the genetic properties of human <italic>USP17 </italic>genes, the complete nucleotide sequences of <italic>USP17K</italic>, <italic>USP17L</italic>, <italic>USP17M</italic>, and <italic>USP17N </italic>[GenBank: <ext-link ext-link-type="gen" xlink:href="AF544011">AF544011</ext-link>, <ext-link ext-link-type="gen" xlink:href="AF544012">AF544012</ext-link>, <ext-link ext-link-type="gen" xlink:href="AY188990">AY188990</ext-link>, and <ext-link ext-link-type="gen" xlink:href="AY533200">AY533200</ext-link>, respectively] were analyzed. Nucleotide and deduced amino acid sequences were analyzed with the SeqEd V1.0.3 program and Clustal method of the MegAlign program, a multiple alignment program of the DNASTAR package. The full-length cDNAs for <italic>USP17K</italic>, <italic>USP17L </italic>and <italic>USP17M </italic>consist of 1593 nucleotides in open reading frame and the deduced amino acid sequence of 530 amino acids with a calculated molecular mass of 58 kDa (<xref ref-type="supplementary-material" rid="S1">Additional File 1</xref>). The full-length cDNA for <italic>USP17N </italic>consists of 1197 nucleotides in open reading frame and the deduced amino acid sequence of 398 amino acids with a calculated molecular weight of 44.5 kDa (<xref ref-type="supplementary-material" rid="S1">Additional File 1</xref>). The conserved Cys, His and Asp domains, which are thought to form the active site of the deubiquitinating enzymes, are also found in the USP17K, USP17L, USP17M and USP17N (Fig. <xref ref-type="fig" rid="F1">1</xref>); these conserved domains have been previously shown in other deubiquitinating enzymes including USP36 [<xref ref-type="bibr" rid="B24">24</xref>], DUB-1 [<xref ref-type="bibr" rid="B25">25</xref>], and DUB-2 [<xref ref-type="bibr" rid="B26">26</xref>]. Sequence analysis for amino acids of novel USP17 subfamily members indicates that USP17K, USP17L and USP17M have high degree of homology (&#x0003e;95%), and USP17N is identical with USP17C when compared with each other and USP17 family members (Table <xref ref-type="table" rid="T1">1</xref>). Phylogenetic analysis for nucleotide sequences and deduced amino acid sequences of novel genes revealed that all novel genes were grouped into the <italic>USP17 </italic>subfamily (Fig. <xref ref-type="fig" rid="F2">2</xref>) and they were characterized in this report.</p><p>Examination of the deduced amino acid sequence of these enzymes by Pfam [<xref ref-type="bibr" rid="B27">27</xref>] revealed that novel subfamily members of USP17 contain the putative conserved hyaluronan binding motifs (Fig. <xref ref-type="fig" rid="F3">3</xref>) -(R/K)X<sub>7</sub>(R/K)- [<xref ref-type="bibr" rid="B28">28</xref>]. These putative motifs are located between amino acid residues Arg 401 to Lys 410, and Lys 445 to Lys 453 (Fig. <xref ref-type="fig" rid="F3">3</xref>). In addition, "RGG" amino acid sequences predicted for the novel RNA binding motif are found at the C-terminus. Interestingly, USP17N lacks of these binding motifs (Fig. <xref ref-type="fig" rid="F3">3</xref>), suggesting the unique functional roles for these motifs. Even though it has been suggested that human USP17 subfamily members are homologous to murine DUB subfamily members due to the fact that they are cytokine-inducible and regulate cell growth and survival [<xref ref-type="bibr" rid="B20">20</xref>], hyaluronan and RNA binding motifs are not found in members of murine DUB subfamily (data not shown).</p></sec><sec><title>Expression of transcripts for novel <italic>USP17 </italic>subfamily members in human tissues and cancerous cells</title><p>To investigate the expression pattern of transcripts for novel <italic>USP17 </italic>subfamily members in human tissues and cancerous cells, Northern blot and RT-PCR analyses were performed. As shown in Figure <xref ref-type="fig" rid="F4">4A</xref>, Northern blot analysis revealed that transcripts for novel <italic>USP17 </italic>subfamily members were expressed in the heart, liver, and pancreas at a high level. Interestingly, we obtained multiple bands having different sizes (1.7 kb, 1.6 kb, 1.3 kb, 1 kb) using a 5' 500 bp probe of <italic>USP17L </italic>(Probe: N-500). We also detected 1.6 kb and 1.7 kb major bands of <italic>USP17 </italic>subfamily members using a probe designed for a 3' 1 kb probe of <italic>USP17L </italic>(Probe: C-1000) (Fig. <xref ref-type="fig" rid="F4">4A</xref>). It is possible that other minor mRNA transcripts around 1.3 kb and 1 kb, which have not been detected with <italic>DUB-3 </italic>probe [<xref ref-type="bibr" rid="B21">21</xref>], may be derived from alternative splicing, promoter usage, or poly (A+) usage. The presence of a few different sizes of transcript indicates that novel genes belong to the <italic>USP17 </italic>subfamily and that there are at least several members of this family present. In addition to various human tissues, RT-PCR analysis showed that the expression of transcripts for novel <italic>USP17 </italic>subfamily members was detected in various human cancer cell lines including HeLa, HEC-1A, NCCIT, and fibrosarcoma cells (Fig. <xref ref-type="fig" rid="F4">4B</xref>).</p></sec><sec><title>Novel USP17 subfamily members as a deubiquitinating enzyme</title><p>To determine whether novel USP17 subfamily proteins have ubiquitin specific protease enzymatic activity, deubiquitinating enzyme assays were performed. For <italic>in vitro </italic>enzyme assay, novel USP17 subfamily members were expressed as a GST fusion protein. As shown by immunoblotting analysis (Fig. <xref ref-type="fig" rid="F5">5</xref>), four GST fusion proteins demonstrated a strong efficient cleavage of Ub-Met-&#x003b2;-gal (Fig. <xref ref-type="fig" rid="F5">5</xref>; lanes 2, 4, 6, and 8). We generated the Cys conserved domain mutant for each of novel USP17 subfamily proteins (C89S) using a site-directed mutagenesis method. As expected, cells with the empty vector alone (Fig. <xref ref-type="fig" rid="F5">5</xref>, lane 1) and mutants (Fig. <xref ref-type="fig" rid="F5">5</xref>; lanes 3, 5, 7 and 9) failed to cleave Ub-Met-&#x003b2;-gal.</p><p>For <italic>in vivo </italic>deubiquitinating enzyme assay, HA-tagged pMT123-ubiquitin was transiently expressed in human endometrial carcinoma cells (HEC-1A) with or without pcDNA3-myc-<italic>USP17L </italic>and pcDNA3-myc-<italic>USP17L </italic>(C89S). Then, we analyzed deubiquitinating enzyme activity by immunoblotting using a monoclonal anti-HA antibody. The expression bands of polyubiquitinated proteins were nearly invisible in cells expressing pcDNA3-myc-<italic>USP17L </italic>(Fig. <xref ref-type="fig" rid="F6">6</xref>; lane 4), but not in cells expressing pcDNA3-myc-<italic>USP17L </italic>(C89S) (Fig. <xref ref-type="fig" rid="F6">6</xref>; lane 5). The molecular weight for a mutant form of USP17L (C89S) is bigger than wild type USP17L, suggesting that there may be a conformational change due to the amino acid substitution. In addition, other USP17 subfamily members showed the deubiquitinating enzyme activity <italic>in vivo </italic>(data not shown). Taken together, we concluded that novel USP17 subfamily proteins have deubiquitinating enzyme activity.</p></sec><sec><title>Hyaluronan/RNA-binding properties of USP17 subfamily proteins</title><p>Since it is not known whether hyaluronan-binding sites within USP17 subfamily proteins are indeed functional, we further examined whether USP17 subfamily proteins actually binds hyaluronan. The cetylpyridinium chloride (CPC)-precipitation assay has been used for investigating binding affinity [<xref ref-type="bibr" rid="B29">29</xref>] and the assay in our study demonstrated that USP17 subfamily proteins interact with hyaluronan based on the comparison of binding intensity between endogenous and exogenous hyaluronans (Fig. <xref ref-type="fig" rid="F7">7A</xref>, lanes 4 and 5). However, USP17N did not interact with hyaluronan (Fig. <xref ref-type="fig" rid="F7">7A</xref>, lane 5), indicating that the C-terminal domain of USP17 subfamily proteins is required for binding with hyaluronan.</p><p>Since it has been reported that the HABP4_PAI-RBP1 domain, which is involved in mRNA stability [<xref ref-type="bibr" rid="B30">30</xref>], interacts with both hyaluronan and RNA [<xref ref-type="bibr" rid="B17">17</xref>], we additionally investigated the activity of USP17 subfamily proteins for binding with RNA. We performed the CPC-precipitation assay and found that USP17 subfamily proteins also bind to RNA in a dose-dependent manner (Figs. <xref ref-type="fig" rid="F7">7A</xref> and <xref ref-type="fig" rid="F7">7B</xref>). Interestingly, USP17N did not interact with RNA as shown with hyaluronan (Fig. <xref ref-type="fig" rid="F7">7A</xref>, lane 6), indicating that the C-terminal domain of USP17 subfamily proteins is also required for binding with RNA.</p></sec><sec><title>Localization study of USP17L</title><p>In order to investigate the intracellular localization of USP17 subfamily proteins, the GFP-tagged USP17L or RFP-tagged USP17N, or both were transfected into HeLa cells. Intriguingly, USP17L proteins are found in the nucleus and are concentrated at the nucleoli (Figs. <xref ref-type="fig" rid="F8">8E</xref> and <xref ref-type="fig" rid="F8">8H</xref>) similar to intracellular hyaluronan [<xref ref-type="bibr" rid="B31">31</xref>]. However, USP17N proteins are localized both in the nucleus and cytoplasm (Figs. <xref ref-type="fig" rid="F8">8F</xref> and <xref ref-type="fig" rid="F8">8I</xref>). A merged format shows that USP17L and USP17N are localized in different regions (Figs. <xref ref-type="fig" rid="F8">8G</xref> and <xref ref-type="fig" rid="F8">8J</xref>). After 48 hours of transfection, cells expressing GFP-tagged USP17L showed the onset of irregular nuclear division and irregular morphology of overall cell shape compared with controls (data not shown). In contrast, cells expressing RFP-tagged <italic>USP17N </italic>did not show any sign of apoptosis, suggesting that hyaluronan binding ability and the localization of USP17 subfamily proteins may be critical for regulating apoptosis leading to cell death.</p></sec><sec><title>Regulation of cell viability</title><p>Since it has been suggested that intracellular hyaluronan binding proteins are involved in tumor formation [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>], we next investigated whether the USP17 subfamily proteins are involved in the regulation of cell viability and cell cycle for cancer cells. In order to investigate the cellular roles of USP17 subfamily proteins, myc-tagged <italic>USP17L </italic>was transfected into HEC-1A and HeLa cells to establish stable cell lines. However, we observed transfected cells undergoing apoptosis (Fig. <xref ref-type="fig" rid="F9">9</xref>) and approximately 3 weeks later, all cells died. However, the transfection of either <italic>USP17L </italic>(C89S) or <italic>USP17N </italic>into the same cell lines did not result in any sign of apoptosis (Fig. <xref ref-type="fig" rid="F9">9</xref>). This indicates that USP17 subfamily proteins containing hyaluronan binding motifs and their substrate(s) may regulate cell viability. Based on the observation of cell death for <italic>USP17L</italic>-transfected cells, we performed quantitative real-time PCR to compare fold change for the expression of caspase 3 as an indicator of apoptosis. The expression of caspase 3 showed more than two fold increase in <italic>USP17L</italic>-transfected cells compared with controls (Fig. <xref ref-type="fig" rid="F10">10</xref>). However, the expression of caspase 3 in <italic>USP17L </italic>(C89S)-transfected cells and in <italic>USP17N</italic>-transfected cells was similar to one in controls (Fig. <xref ref-type="fig" rid="F10">10</xref>). All reactions were performed triplicate.</p><p>In order to confirm the apoptosis induced by USP17 subfamily proteins, <italic>USP17L </italic>was stably expressed by the Tet-on system. The morphology of cells undergoing apoptosis was similar to that of ones transfected with pcDNA3-myc-<italic>USP17L </italic>(data not shown). Therefore, we harvested the <italic>USP17L</italic>-expressing cells at 1 week intervals for 3 weeks and analyzed through FACS analysis. The rate of apoptosis for cells expressing either <italic>USP17L </italic>or <italic>USP17L </italic>(CS) was analyzed by double-staining with annexin V and PI (Fig. <xref ref-type="fig" rid="F11">11</xref>). The cell stages of apoptosis were differentiated depending on the location in the quadrant (annexin V +, PI -; early stage) and (annexin V +, PI +; late stage) [<xref ref-type="bibr" rid="B34">34</xref>]. The <italic>USP17L</italic>-expressing cells by the Tet-on system undergoing the early stage apoptosis showed about 2.5 fold increase compared with control HeLa cells and those undergoing late stage apoptosis showed about 1.5 fold increase (Fig. <xref ref-type="fig" rid="F11">11</xref>). However, the significant change was not observed in cells expressing <italic>USP17L </italic>(CS) or <italic>USP17N </italic>(Fig. <xref ref-type="fig" rid="F11">11</xref>). This experiment was performed triplicate.</p></sec></sec><sec><title>Discussion</title><p>The ubiquitin-mediated protein degradation pathway has diverse functions involved in the regulation of protein activity, indicating the importance of the system in eukaryotic cells. Specific modulation by diverse deubiquitinating enzyme is a key process controlling many proteins associated with the ubiquitin-proteasome system. In this study, we isolated four novel members of <italic>USP17 </italic>subfamily and showed through sequence analysis that they have high degree of homology when compared with each other and <italic>USP17 </italic>(<xref ref-type="supplementary-material" rid="S1">Additional File 1</xref>). Phylogenetic analysis for nucleotide sequences and deduced amino acid sequences of <italic>USP17 </italic>subfamily members revealed that all novel genes were grouped into the <italic>USP17 </italic>subfamily (Fig. <xref ref-type="fig" rid="F1">1</xref>). It has been recently reported that there are multiple homologous genomic sequences of <italic>USP17 </italic>subfamily, and one of them, <italic>DUB-3</italic>, encodes a cytokine-inducible deubiquitinating enzyme [<xref ref-type="bibr" rid="B21">21</xref>]. This is similar to murine <italic>DUB </italic>subfamily members including <italic>DUB-1</italic>, <italic>DUB-2</italic>, <italic>DUB-2A</italic>, and <italic>DUB-1A </italic>[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. However, whether they have distinct functions or polymorphisms remains to be seen.</p><p>Since <italic>USP17 </italic>transcripts were expressed in various cancer cell lines and it has been suggested that intracellular hyaluronan binding proteins, which USP17 subfamily members belong to, are involved in tumor formation [<xref ref-type="bibr" rid="B33">33</xref>], we investigated whether USP17 subfamily proteins are involved in cell growth and proliferation. Interestingly, we observed that cancer cells (HeLa and HEC-1A) overexpressing USP17 subfamily proteins except USP17N appeared morphologically abnormal. In addition, FACS analysis showed that double-staining of USP17L-expressing, but not USP17N-expressing cells with annexin V and PI revealed increased apoptosis (Figs. <xref ref-type="fig" rid="F11">11A</xref> and <xref ref-type="fig" rid="F11">11B</xref>). These results suggest that USP17 subfamily proteins containing hyaluronan and RNA binding motifs are involved in signaling pathway of death for tumorigenic cells.</p><p>Besides the fact that the overexpression of USP17 subfamily proteins induces apoptosis in cancer cells, the ability to bind with hyaluronan is another important point used to elucidate the cellular functions of USP17 subfamily proteins. Hyaluronan is one of glycosaminoglycans and is believed to play various roles both in extracellular and pericellular matrices [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Since enriched hyaluronan is found in various tumor tissues [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>], it was thought to be important for cancer. Several evidences have been proposed to prove the connection between hyaluronan and tumor growth. Therefore, hyaluronan is used as a marker for various cancers these days [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. In addition, hyaluronan has been suggested that it is involved in the fundamental regulation of cell cycle, because hyaluronan is enriched in the nucleus during the cell division [<xref ref-type="bibr" rid="B31">31</xref>]. Since USP17 subfamily proteins except USP17N binds to hyaluronan and induces cell death, it is possible that hyaluronan and/or RNA binding domains of USP17 subfamily proteins may be involved in the regulation of cell cycle or tumorigenesis. Another possibility is that hyaluronan may serve as a bridge between the USP17 subfamily enzymes and their potential substrates, which are intracellular hyaluronan-binding proteins. Moreover, USP17 subfamily proteins are condensed at the nucleoli like hyaluronan dose, suggesting that USP17 subfamily proteins are involved in mRNA stability or chromatin remodeling similar to functions of PAI-RBP1 and Ki-1/57, which are hyaluronan/RNA binding motif-containing proteins [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Due to the fact that <italic>in vivo </italic>deubiquitinating enzyme assay for USP17 subfamily members showed the extensive reduction of ubiquitination for cellular proteins (Fig. <xref ref-type="fig" rid="F6">6</xref>), it is possible that a number of proteins including apoptosis-related proteins can be regulated by USP17 subfamily members. Important direction for future studies should include the isolation and characterization of substrates for USP17. This will help us to understand the cellular roles of USP17.</p></sec><sec><title>Conclusion</title><p>In this study, we report that four novel USP17 subfamily members which encode a deubiquitinating enzyme have been identified and that the overexpression of these proteins leads to cell death. Our study demonstrates that USP17 subfamily members, which regulate apoptosis and cell death of cancerous cells, contain putative hyaluronan and RNA binding motifs. Despite of a decade of research since the discovery of DUB enzymes as an important molecule responsible for regulating protein degradation, much remains to be defined regarding their cellular functions. A better understanding of relation between USP17 subfamily proteins and cell viability will facilitate therapeutic strategies for regulation of cell proliferation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Specimens and transfection</title><p>Chorionic villi samples used were described previously [<xref ref-type="bibr" rid="B36">36</xref>]. Various human cancer cells (HeLa, HEC-1A, NCCIT, and fibrosarcoma cells) were cultured in DMEM (Gibco BRL, Rockville, MD, USA) supplemented with 10% fetal bovine serum (Gibco BRL, Rockville, MD, USA). Transfection was performed with LipofectAMINE reagent (Gibco BRL, Rockville, MD, USA) according to manufacturer's instruction.</p></sec><sec><title>cDNA synthesis and cloning for <italic>USP17 </italic>subfamily members</title><p>TRIzol reagent (Gibco BRL, Rockville, MD, USA) was used for total RNA isolation from obtained chorionic villi, HeLa, HEC-1A, NCCIT, and fibrosarcoma cells. cDNA synthesis from obtained total RNA was in accordance with the protocol of SuperScript Preamplification system (Gibco BRL, Rockville, MD, USA). The full-length cDNAs were amplified by RT-PCR in human chorionic villi tissues, HeLa, HEC-1A, NCCIT, and fibrosarcoma cells. Primers (Forward: 5'-CGGGATCCATGGAGGACG-3', Reverse: 5'-GGAATTCCACTGAGATCACT-3') used for isolating putative <italic>DUB </italic>genes are made on the basis of published sequences [GenBank: <ext-link ext-link-type="gen" xlink:href="XM_252830">XM_252830</ext-link>]. Primers used were synthesized commercially and gel-purified prior to use (Bioneer, Daejeon, Korea). To express GST fusion proteins, pGEX-2TK-<italic>USP17K</italic>, pGEX-2TK-<italic>USP17L</italic>, pGEX-2TK-<italic>USP17M</italic>, and pGEX-2TK-<italic>USP17N </italic>were cloned by inserting each <italic>USP17 </italic>subfamily member into pGEX-2TK vector (Amersham Life Science, Uppsala, Sweden). BLAST programs on the web site established by the National Center of Biological Information [<xref ref-type="bibr" rid="B37">37</xref>] were used for similarity searches in the GenBank, and Pfam [<xref ref-type="bibr" rid="B27">27</xref>] program was used for prediction of possible motifs and domains in the protein sequences.</p></sec><sec><title>Site-directed mutagenesis of <italic>USP17 </italic>subfamily members</title><p>Missense mutation constructs for pGEX-2TK-<italic>USP17K </italic>(C89S), pGEX-2TK-<italic>USP17L </italic>(C89S), pGEX-2TK-<italic>USP17M </italic>(C89S), and pGEX-2TK-<italic>USP17N </italic>(C89S) were derived from each wild type construct by PCR-based site-directed mutagenesis, using a QuikChange&#x02122; Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) according to manufacturers' instructions. The two primers; forward primer (5'-GGGAAATACCCGCTACGTGAACGCTTC-3') and reverse primer (5'-GAAGCGTTCACGTAGCGGGTATTTCC-3') were used for replacing cysteine with serine at amino acid 89 of <italic>USP17 </italic>subfamily proteins. Primers used were synthesized commercially and gel-purified prior to use (Bioneer, Daejeon, Korea).</p></sec><sec><title>Northern blot analysis</title><p>As described previously [<xref ref-type="bibr" rid="B36">36</xref>], Northern blot analysis was carried out to confirm the expression level of <italic>USP17 </italic>transcripts using a human tissue blot purchased from Clontech. The immobilized nucleic acids were hybridized with radiolabeled DNA probes. Probes used for this study was the 5' 500 bp and 3' 1 kb of <italic>USP17L</italic>. They were labeled by random primers with [<sup>32</sup>P]dCTP (Amersham Biosciences, Buckinghamshire, England). Hybridization was performed in a bag containing 5 &#x000d7; SSC, 1 &#x000d7; Denhardt's solution, 100 &#x003bc;g/ml of denatured salmon sperm DNA, 0.1% SDS and 50% formamide at 60&#x000b0;C and it was washed in 0.1 &#x000d7; SSC and 0.2% SDS, the membrane was exposed to Kodak X-ray films with an intensifying screen for 24 hours at -70&#x000b0;C.</p></sec><sec><title>Deubiquitinating enzyme assays</title><p>Deubiquitinating enzyme assays were previously described [<xref ref-type="bibr" rid="B9">9</xref>]. For the <italic>in vitro </italic>deubiquitination assay, pGEX-2TK-<italic>USP17K</italic>, pGEX-2TK-<italic>USP17K </italic>(C89S), pGEX-2TK-<italic>USP17L</italic>, pGEX-2TK-<italic>USP17L </italic>(C89S), pGEX-2TK-<italic>USP17M</italic>, pGEX-2TK-<italic>USP17M </italic>(C89S), pGEX-2TK-<italic>USP17N</italic>, and pGEX-2TK-<italic>USP17N </italic>(C89S) were co-transformed into <italic>E. coli </italic>BL21 competent cells (Stratagene, La Jolla, CA, USA) with pACYC184-Ub-&#x003b2;-gal. Plasmid-bearing <italic>E. coli </italic>BL21 cells were grown in LB medium and induced with isopropyl-1-thio-&#x003b2;-D-galactopyranoside (IPTG) for 4 hours at 37&#x000b0;C. Cells were harvested and were lysed in cracking buffer (0.01 M phosphate [pH 7.4]. 8 M Urea, 1% SDS, and 1% &#x003b2;-mercaptoethanol). These whole cell lysates centrifuged for 10 min at 14,000 rpm and the supernatant was loaded onto a 7.5% SDS-PAGE gel. The immunoblotting was performed with a rabbit anti-&#x003b2;-gal antiserum (ICN, Costa Mesa, CA, USA) or a rabbit anti-GST antiserum (Upstate Biotechnology, Lake Placid, NY, USA).</p><p>The effect of <italic>USP17 </italic>expression on the ubiquitin-proteasome system <italic>in vivo </italic>was analyzed by transfecting pcDNA3-myc-<italic>USP17L </italic>or pcDNA3-myc-<italic>USP17L </italic>(C89S) along with pMT123-HA-ubiquitin into HEC-1A cells. After 24 hours of transfection, cells were harvested and lysed. 40 &#x003bc;g of total proteins was loaded in each lane of a 10% SDS-PAGE for immunoblotting analysis using an anti-HA antibody (Roche Applied Science, Mannheim, Germany). Equal loading was verified by immunoblotting against &#x003b1;-myc (Santa Cruz Biotechnology, Santa Cruz, CA, USA).</p></sec><sec><title>Real-time PCR analysis and the Tet-on system</title><p>After the transfection of pcDNA3-myc-<italic>USP17L</italic>, the expression of caspase 3 as a marker for apoptosis was analyzed by real-time PCR (Opticon2, MJ Research, Ramsey, MN, USA). Product specificity was examined by melting curve analysis and agarose gel electrophoresis after each real-time PCR reaction. To normalize the expression data of the genes, GAPDH was used (Forward primer: 5'-ACTGGTGCTGCCAAGGCTGT-3', Reverse primer: 5'-TCCACCACCCTGTTGCTGTA-3'). Quantification was performed using an internal cDNA standard curve. Fold changes of caspase 3 expression in <italic>USP17L</italic>-overexpressed cells were calculated relative to the levels in control cells.</p><p>For the long-term (3 weeks) observation and FACS analysis, <italic>USP17L </italic>was expressed in HeLa cells using the Tet-on system (Gibco BRL, Rockville, MD, USA) by manufacturer's instruction. Expression of <italic>USP17L </italic>was confirmed by real-time PCR analysis.</p></sec><sec><title>FACS analysis</title><p>For apoptosis analysis, HeLa-Tet-on cells expressing <italic>USP17L </italic>were harvested in PBS and resuspended 100 &#x003bc;l of binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl<sub>2</sub>). 5 &#x003bc;l annexin V-FITC (BD Biosciences, Bedford, MA, USA) and 10 &#x003bc;l propidium iodide (PI, 50 &#x003bc;g/ml, BD Biosciences, Bedford, MA, USA) were added and incubated 15 minutes in the dark. Finally 400 &#x003bc;l of binding buffer was added and analyzed by FACSVantage&#x02122; SE system (BD Biosciences, Bedford, MA, USA). Cells in stage of apoptosis were differentiated depending on the location in quadrant (annexin V +, PI -; early stage) and (annexin V +, PI +; late stage) [<xref ref-type="bibr" rid="B34">34</xref>].</p></sec><sec><title>Localization study</title><p><italic>USP17L </italic>and <italic>USP17N </italic>were subcloned into pEGFP-C1 and pDsRed-C1 (Clontech, Palo Alto, CA, USA), respectively, and transfected into HeLa cells using ExGen500 (Fermentas, Hanover, MD, USA). After 48 hours, the localization of GFP-tagged <italic>USP17L </italic>and RFP-tagged <italic>USP17N </italic>was observed using a confocal microscopy (Radiance 2100 2Q, Bio-Rad, Hercules, CA, USA). In order to observe the morphology of nuclei for HeLa cells, DAPI staining was performed. After the fixation, 5 &#x003bc;l of DAPI staining solution (Roche Applied Science, Mannheim, Germany) was added in wells containing HeLa cells, which express either GFP-tagged <italic>USP17L </italic>or RFP-tagged <italic>USP17N</italic>. Stained cells were observed using Nikon Eclipse E600 microscopy.</p></sec><sec><title>Hyaluronan- and RNA-binding assays</title><p>These assays were previously described [<xref ref-type="bibr" rid="B29">29</xref>]. 9 &#x003bc;g of pcDNA3-myc-<italic>USP17L </italic>or pcDNA3-myc-<italic>USP17N </italic>was transiently transfected into 1 &#x000d7; 10<sup>6 </sup>HeLa cells in 100&#x003a6; dish by ExGen500 transfection reagent (Fermentas, Hanover, MD, USA). The supernatant from lysates was divided into 100 &#x003bc;l aliquots in Eppendorf tube and incubated at room temperature with 50 &#x003bc;g of hyaluronan (H5388, Sigma, St. Louis, MO, USA). For RNA binding assay, this procedure was repeated with using total RNA of HeLa cells instead of hyaluronan.</p></sec></sec><sec><title>Abbreviations</title><p>CPC, cetylpyridinium chloride; DUB, deubiquitinating enzyme; E1, ubiquitin-activating enzyme; E2, ubiquitin-conjugating enzyme; E3, ubiquitin ligase; ECL, enhanced chemiluminescence; GST, glutathione <italic>S</italic>-transferase; HA, hemagglutinin; IHABPS, intracellular hyaluronan binding proteins; IP, immunoprecipitation; JAMM, Jab1/Pab1/MPN-domain-containing metallo-enzyme; OTU, otu-domain ubiquitin aldehyde-binding protein; PCR, polymerase chain reaction; PI, propidium iodide; RHAMM, receptor form hyaluronan-mediated motility; SDS-PAGE; sodium dodecyl sulfate-polyacrylamide gel electrophoresis; Ub, ubiquitin; UBP, ubiquitin specific processing protease; UCH, ubiquitin C-terminal hydrolase.</p></sec><sec><title>Authors' contributions</title><p>JMS participated in molecular cloning, sequence alignment and immunoassay. KJY carried out the molecular cloning and binding assays. MSK carried out the immunoassay and microscopic assay. DK carried out FACS analysis. KHB conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional File 1</title><p>Alignment of amino acid sequences for USP17, DUB-3, and novel USP17 subfamily members (USP17K to USP17N) (GenBank accession numbers: <ext-link ext-link-type="gen" xlink:href="AY509884">AY509884</ext-link>, <ext-link ext-link-type="gen" xlink:href="BC100991">BC100991</ext-link>, <ext-link ext-link-type="gen" xlink:href="AF544011">AF544011</ext-link>, <ext-link ext-link-type="gen" xlink:href="AF544012">AF544012</ext-link>, <ext-link ext-link-type="gen" xlink:href="AY188990">AY188990</ext-link>, and <ext-link ext-link-type="gen" xlink:href="AY533200">AY533200</ext-link>, respectively) using MegAlign software (Clustal method) from DNA Star (LaserGene). Different amino acids are blocked.</p></caption><media xlink:href="1471-2164-7-292-S1.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We wish to thank the members of the Fertility Medical Center and Cell and Gene Therapy Research Institute at Pochon CHA University and CHA General Hospital. We thank Dr. Bryan P. Toole for his advice on hyaluronan binding assay. We also would like to thank Dr. Natalie Beaty at NIH for her critical comments on the manuscript and Sung-Hwan Moon for his technical assistance for confocal microscope. This work was supported by Korea Research Foundation Grant funded by Korea Government (MOEHRD, Basic Research Promotion Fund) (KRF-2005-015-C00284).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>KH</given-names></name></person-group><article-title>Cytokine-regulated protein degradation by the ubiquitination system</article-title><source>Curr Protein Pept Sci</source><year>2006</year><volume>7</volume><fpage>171</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">16611142</pub-id><pub-id pub-id-type="doi">10.2174/138920306776359740</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciechanover</surname><given-names>A</given-names></name></person-group><article-title>ubiquitin-proteasome pathway: on protein death and cell life</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>7151</fpage><lpage>7160</lpage><pub-id pub-id-type="pmid">9857172</pub-id><pub-id pub-id-type="doi">10.1093/emboj/17.24.7151</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cadavid</surname><given-names>AL</given-names></name><name><surname>Ginzel</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>JA</given-names></name></person-group><article-title>The function of the <italic>Drosophila </italic>Fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1727</fpage><lpage>1736</lpage><pub-id pub-id-type="pmid">10725248</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantaleon</surname><given-names>M</given-names></name><name><surname>Kanai-Azuma</surname><given-names>M</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name><name><surname>Kaibuchin</surname><given-names>K</given-names></name><name><surname>Kaye</surname><given-names>PL</given-names></name><name><surname>Wood</surname><given-names>SA</given-names></name></person-group><article-title>FAM deubiquitinating enzyme is essential for preimplantation mouse embryo development</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><fpage>151</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">11731229</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00551-2</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>A</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><article-title>Deubiquitinating enzymes: a new class of biological regulators</article-title><source>Crit Rev Biochem Mol Biol</source><year>1998</year><volume>33</volume><fpage>337</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">9827704</pub-id><pub-id pub-id-type="doi">10.1080/10409239891204251</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewies</surname><given-names>A</given-names></name><name><surname>Grimm</surname><given-names>S</given-names></name></person-group><article-title>UBP41 is a proapoptotic ubiquitin-specific protease</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>682</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">12566314</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koegl</surname><given-names>M</given-names></name><name><surname>Hoppe</surname><given-names>T</given-names></name><name><surname>Schlenker</surname><given-names>S</given-names></name><name><surname>Ulrich</surname><given-names>HD</given-names></name><name><surname>Mayer</surname><given-names>TU</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name></person-group><article-title>A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly</article-title><source>Cell</source><year>1999</year><fpage>635</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">10089879</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80574-7</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amerik</surname><given-names>AY</given-names></name><name><surname>Hochstrasser</surname><given-names>M</given-names></name></person-group><article-title>Mechanism and function of deubiquitinating ezymes</article-title><source>Biochim Biophys Acta</source><year>2004</year><volume>1695</volume><fpage>189</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">15571815</pub-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2004.10.003</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Shin</surname><given-names>JM</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name></person-group><article-title>DUB-1A, a novel subfamily member of deubiquitinating enzyme, is polyubiquitinated and cytokine inducible in B-lymphocytes</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>2368</fpage><lpage>2376</lpage><pub-id pub-id-type="pmid">14583620</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M304774200</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cope</surname><given-names>GA</given-names></name><name><surname>Suh</surname><given-names>GS</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name><name><surname>Schwarz</surname><given-names>SE</given-names></name><name><surname>Zipursky</surname><given-names>SL</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name><name><surname>Deshaies</surname><given-names>RJ</given-names></name></person-group><article-title>Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>608</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12183637</pub-id><pub-id pub-id-type="doi">10.1126/science.1075901</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>R</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name><name><surname>Oania</surname><given-names>R</given-names></name><name><surname>McDonald</surname><given-names>WH</given-names></name><name><surname>Yates</surname><given-names>JR</given-names><suffix>III</suffix></name><name><surname>Koonin</surname><given-names>EV</given-names></name><name><surname>Deshaies</surname><given-names>RJ</given-names></name></person-group><article-title>Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>611</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">12183636</pub-id><pub-id pub-id-type="doi">10.1126/science.1075898</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>PC</given-names></name><name><surname>Smith</surname><given-names>TS</given-names></name><name><surname>Lai</surname><given-names>MJ</given-names></name><name><surname>Williams</surname><given-names>MG</given-names></name><name><surname>Burke</surname><given-names>DF</given-names></name><name><surname>Heyninck</surname><given-names>K</given-names></name><name><surname>Kreike</surname><given-names>MM</given-names></name><name><surname>Beyaert</surname><given-names>R</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Kilshaw</surname><given-names>PJ</given-names></name></person-group><article-title>A novel type of deubiquitinating enzyme</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>23180</fpage><lpage>23186</lpage><pub-id pub-id-type="pmid">12682062</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M301863200</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hascall</surname><given-names>VC</given-names></name><name><surname>Majors</surname><given-names>AK</given-names></name><name><surname>De La Motte</surname><given-names>CA</given-names></name><name><surname>Evanko</surname><given-names>SP</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Drazaba</surname><given-names>JA</given-names></name><name><surname>Strong</surname><given-names>SA</given-names></name><name><surname>Wight</surname><given-names>TN</given-names></name></person-group><article-title>Intracellular hyaluronan: a new frontier for inflammation?</article-title><source>Biochim Biophys Acta</source><year>2004</year><volume>1673</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15238245</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Toole</surname><given-names>BP</given-names></name><name><surname>Kinney</surname><given-names>SD</given-names></name><name><surname>Kuo</surname><given-names>JW</given-names></name><name><surname>Stamenkovic</surname><given-names>I</given-names></name></person-group><article-title>Inhibition of tumor growth <italic>in vivo </italic>by hyaluronan oligomers</article-title><source>Int J Cancer</source><year>1999</year><volume>77</volume><fpage>396</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">9663602</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19980729)77:3&#x0003c;396::AID-IJC15&#x0003e;3.0.CO;2-6</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savani</surname><given-names>RC</given-names></name><name><surname>Cao</surname><given-names>G</given-names></name><name><surname>Pooler</surname><given-names>PM</given-names></name><name><surname>Zaman</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>DeLisser</surname><given-names>HM</given-names></name></person-group><article-title>Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>36770</fpage><lpage>36778</lpage><pub-id pub-id-type="pmid">11448954</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M102273200</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collis</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Lange</surname><given-names>L</given-names></name><name><surname>Ziebell</surname><given-names>M</given-names></name><name><surname>Prestwich</surname><given-names>R</given-names></name><name><surname>Turley</surname><given-names>EA</given-names></name></person-group><article-title>Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action</article-title><source>FEBS Lett</source><year>1998</year><volume>440</volume><fpage>444</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">9872419</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01505-1</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Grammatikakis</surname><given-names>N</given-names></name><name><surname>Yoneda</surname><given-names>M</given-names></name><name><surname>Banerjee</surname><given-names>SD</given-names></name><name><surname>Toole</surname><given-names>BP</given-names></name></person-group><article-title>Molecular characterization of a novel intracellular hyaluronan-binding protein</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>29829</fpage><lpage>29839</lpage><pub-id pub-id-type="pmid">10887182</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M002737200</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohapatra</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wright</surname><given-names>JA</given-names></name><name><surname>Turley</surname><given-names>EA</given-names></name><name><surname>Greenberg</surname><given-names>AH</given-names></name></person-group><article-title>Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>1663</fpage><lpage>1668</lpage><pub-id pub-id-type="pmid">8666924</pub-id><pub-id pub-id-type="doi">10.1084/jem.183.4.1663</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>CA</given-names></name><name><surname>Keats</surname><given-names>JJ</given-names></name><name><surname>Crainie</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Yen</surname><given-names>T</given-names></name><name><surname>Shibuya</surname><given-names>E</given-names></name><name><surname>Hendzel</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>G</given-names></name><name><surname>Pilarski</surname><given-names>LM</given-names></name></person-group><article-title>RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability</article-title><source>Mol Biol Cell</source><year>2003</year><volume>14</volume><fpage>2262</fpage><lpage>2276</lpage><pub-id pub-id-type="pmid">12808028</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E02-07-0377</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burrows</surname><given-names>JF</given-names></name><name><surname>McGrattan</surname><given-names>MJ</given-names></name><name><surname>Johnston</surname><given-names>JA</given-names></name></person-group><article-title>The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence</article-title><source>Genomics</source><year>2005</year><volume>85</volume><fpage>524</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">15780755</pub-id><pub-id pub-id-type="doi">10.1016/j.ygeno.2004.11.013</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burrows</surname><given-names>JF</given-names></name><name><surname>McGrattan</surname><given-names>MJ</given-names></name><name><surname>Rascle</surname><given-names>A</given-names></name><name><surname>Humbert</surname><given-names>M</given-names></name><name><surname>Baek</surname><given-names>KH</given-names></name><name><surname>Johnston</surname><given-names>JA</given-names></name></person-group><article-title>DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>13993</fpage><lpage>14000</lpage><pub-id pub-id-type="pmid">14699124</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M311291200</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>KH</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Choi</surname><given-names>HK</given-names></name></person-group><article-title>Molecular cloning and complete cDNA sequence of UBH1 in mouse testis</article-title><source>DNA Seq</source><year>2002</year><volume>13</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">12391724</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>T</given-names></name><name><surname>Gondo</surname><given-names>Y</given-names></name><name><surname>Goto</surname><given-names>J</given-names></name><name><surname>Kanazawa</surname><given-names>I</given-names></name><name><surname>Hadano</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>JE</given-names></name></person-group><article-title>Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene</article-title><source>Hum Genet</source><year>2002</year><volume>110</volume><fpage>302</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">11941478</pub-id><pub-id pub-id-type="doi">10.1007/s00439-002-0698-2</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Seong</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Baek</surname><given-names>KH</given-names></name></person-group><article-title>Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>330</volume><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">15809067</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.03.051</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Caroll</surname><given-names>M</given-names></name><name><surname>Papa</surname><given-names>FR</given-names></name><name><surname>Hochstrasser</surname><given-names>M</given-names></name><name><surname>D'Andrea</surname><given-names>AD</given-names></name></person-group><article-title>DUB-1, a deubiquitinating enzymes with growth-suppressing activity</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>3275</fpage><lpage>3279</lpage><pub-id pub-id-type="pmid">8622927</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.8.3275</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Lambert</surname><given-names>K</given-names></name><name><surname>Corless</surname><given-names>C</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Gilbert</surname><given-names>DJ</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>D'Andrea</surname><given-names>AD</given-names></name></person-group><article-title>DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8995226</pub-id><pub-id pub-id-type="doi">10.1074/jbc.272.1.51</pub-id></citation></ref><ref id="B27"><citation citation-type="other"><article-title>Pfam</article-title><ext-link ext-link-type="uri" xlink:href="http://www.sanger.ac.kr/Software/Pfam/"/></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>CL</given-names></name><name><surname>Yang</surname><given-names>BL</given-names></name><name><surname>Savani</surname><given-names>RC</given-names></name><name><surname>Turley</surname><given-names>EA</given-names></name></person-group><article-title>Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein</article-title><source>EMBO J</source><year>1994</year><volume>13</volume><fpage>286</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">7508860</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sleeman</surname><given-names>JP</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Moll</surname><given-names>J</given-names></name><name><surname>Ponta</surname><given-names>H</given-names></name><name><surname>Herrlich</surname><given-names>P</given-names></name></person-group><article-title>Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44</article-title><source>J Biol Chem</source><year>1996</year><volume>272</volume><fpage>31837</fpage><lpage>31844</lpage><pub-id pub-id-type="pmid">9395530</pub-id><pub-id pub-id-type="doi">10.1074/jbc.272.50.31837</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heaton</surname><given-names>JH</given-names></name><name><surname>Dlakic</surname><given-names>WM</given-names></name><name><surname>Dlakic</surname><given-names>M</given-names></name><name><surname>Gelehrter</surname><given-names>TD</given-names></name></person-group><article-title>Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>3341</fpage><lpage>3347</lpage><pub-id pub-id-type="pmid">11001948</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M006538200</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evanko</surname><given-names>SP</given-names></name><name><surname>Wight</surname><given-names>TN</given-names></name></person-group><article-title>Intracellular localization of hyaluronan in proliferating cells</article-title><source>J Histochem Cytochem</source><year>1999</year><volume>47</volume><fpage>1331</fpage><lpage>1342</lpage><pub-id pub-id-type="pmid">10490462</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toole</surname><given-names>BP</given-names></name></person-group><article-title>Hyaluronan: from extracellular glue to pericellular cue</article-title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><fpage>528</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">15229478</pub-id><pub-id pub-id-type="doi">10.1038/nrc1391</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toole</surname><given-names>BP</given-names></name><name><surname>Wight</surname><given-names>TN</given-names></name><name><surname>Tammi</surname><given-names>MI</given-names></name></person-group><article-title>Hyaluronan-cell interactions in cancer and vascular disease</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>4593</fpage><lpage>4596</lpage><pub-id pub-id-type="pmid">11717318</pub-id><pub-id pub-id-type="doi">10.1074/jbc.R100039200</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savitskiy</surname><given-names>VP</given-names></name><name><surname>Shman</surname><given-names>TV</given-names></name><name><surname>Potapnev</surname><given-names>MP</given-names></name></person-group><article-title>Comparative measurement of spontaneous apoptosis in pediatric acute leukaemia by different techniques</article-title><source>Cytometry B Clin Cytom</source><year>2003</year><volume>56</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">14582133</pub-id><pub-id pub-id-type="doi">10.1002/cyto.b.10056</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evanko</surname><given-names>SP</given-names></name><name><surname>Angello</surname><given-names>JC</given-names></name><name><surname>Wight</surname><given-names>TN</given-names></name></person-group><article-title>Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1999</year><volume>19</volume><fpage>1004</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">10195929</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HK</given-names></name><name><surname>Choi</surname><given-names>BC</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Cha</surname><given-names>KY</given-names></name><name><surname>Baek</surname><given-names>KH</given-names></name></person-group><article-title>Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients</article-title><source>Mol Reprod Dev</source><year>2003</year><volume>66</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12874795</pub-id><pub-id pub-id-type="doi">10.1002/mrd.10331</pub-id></citation></ref><ref id="B37"><citation citation-type="other"><article-title>National Center of Biological Information (NCBI)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST/"/></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Conserved domains of USP17 subfamily members were compared with other deubiquitinating enzymes including human USP36, mouse DUB-1, and DUB-2. These domains are critical for the function of deubiquitinating enzymes.</p></caption><graphic xlink:href="1471-2164-7-292-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Phylogenetic tree assignments of USP17 subfamily members. Sequence names and GenBank accession numbers are as follows: USP17, <ext-link ext-link-type="gen" xlink:href="AY509884">AY509884</ext-link>; DUB-3, <ext-link ext-link-type="gen" xlink:href="BC100991">BC100991</ext-link>; USP17A, <ext-link ext-link-type="gen" xlink:href="XM_377832">XM_377832</ext-link>; USP17B, <ext-link ext-link-type="gen" xlink:href="XM_373239">XM_373239</ext-link>; USP17C, <ext-link ext-link-type="gen" xlink:href="NM_212553">NM_212553</ext-link>; USP17D, <ext-link ext-link-type="gen" xlink:href="XM_373021">XM_373021</ext-link>; USP17F, <ext-link ext-link-type="gen" xlink:href="XM_376741">XM_376741</ext-link>; USP17G, <ext-link ext-link-type="gen" xlink:href="XM_376754">XM_376754</ext-link>; USP17H, <ext-link ext-link-type="gen" xlink:href="XM_377837">XM_377837</ext-link>; USP17I, <ext-link ext-link-type="gen" xlink:href="XM_377835">XM_377835</ext-link>; USP17J, <ext-link ext-link-type="gen" xlink:href="XM_377834">XM_377834</ext-link>; USP17K, <ext-link ext-link-type="gen" xlink:href="AF544011">AF544011</ext-link>; USP17L, <ext-link ext-link-type="gen" xlink:href="AF544012">AF544012</ext-link>; USP17M, <ext-link ext-link-type="gen" xlink:href="AY188990">AY188990</ext-link>, USP17N, <ext-link ext-link-type="gen" xlink:href="AY533200">AY533200</ext-link>. Novel members of USP17 subfamily are underlined. USP17E sequence identified previously [20] could not be located with the reported GenBank accession number (<ext-link ext-link-type="gen" xlink:href="NM_001324">NM_001324</ext-link>).</p></caption><graphic xlink:href="1471-2164-7-292-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p>Schematic diagram of structural features for USP17 subfamily members. The domains required for deubiquitinating activity (Cys, Asp (I) His, Asp/Asn (II)) are located at the 5' end and middle of enzymes. Two potential hyaluronan binding motifs R/K(X<sub>7</sub>)R/K are located at amino acids 401 to 410, and 445 to 453.</p></caption><graphic xlink:href="1471-2164-7-292-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Northern blot analysis for <italic>USP17 </italic>subfamily members in human tissues and RT-PCR analysis in human tumor cell lines. (A) Northern blot analysis was carried out to investigate the expression level of USP17 subfamily members in human tissues. The 5' 500 bp- and 3' 1 kb-probes of <italic>USP17L </italic>were used. The multiple transcript sizes of <italic>USP17 </italic>mRNA including 1.6 kb were detected. The same blot was probed with the human &#x003b2;-actin as a loading control. (B) Global expression of <italic>USP17 </italic>subfamily members in various cancer cell lines.</p></caption><graphic xlink:href="1471-2164-7-292-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p>Deubiquitinating enzyme assays for novel USP17 subfamily members. <italic>In vitro </italic>deubiquitinating enzyme activity for USP17K, USP17L, USP17M, and USP17N. Immunoblotting analysis was performed with anti-&#x003b2;-gal antiserum. Coexpressed plasmids were pGEX-2TK (lane 1), pGEX-2TK-<italic>USP17K </italic>(lane 2), pGEX-2TK-<italic>USP17K </italic>(C89S) (lane 3), pGEX-2TK-<italic>USP17L </italic>(lane 4), pGEX-2TK-<italic>USP17L </italic>(C89S) (lane 5), pGEX-2TK-<italic>USP17M </italic>(lane 6), pGEX-2TK-<italic>USP17M </italic>(C89S) (lane 7), pGEX-2TK-<italic>USP17N </italic>(lane 8), and pGEX-2TK-<italic>USP17N </italic>(C89S) (lane 9). All of normal USP17 subfamily members cleaved the linkage between ubiquitin and &#x003b2;-galactosidase.</p></caption><graphic xlink:href="1471-2164-7-292-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><italic>In vivo </italic>deubiquitinating enzyme assay for the novel USP17 subfamily member. HA-tagged pMT123-<italic>ubiquitin </italic>was transiently expressed in HEC-1A cells with or without pcDNA3-<italic>myc</italic>-<italic>USP17L </italic>and pcDNA3-<italic>myc</italic>-<italic>USP17L </italic>(C89S). The expression levels of polyubiquitinated proteins were decreased in cells expressing pcDNA3-<italic>myc</italic>-<italic>USP17L</italic>, but not in cells expressing pcDNA3-<italic>myc</italic>-<italic>USP17L </italic>(C89S).</p></caption><graphic xlink:href="1471-2164-7-292-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p>Hyaluronan/RNA-binding assays. To confirm the interaction of USP17 subfamily proteins with either hyaluronan or RNA, CPC precipitation assay was performed. Cell lysate aliquots from HeLa cells transfected with myc-tagged <italic>USP17L </italic>or myc-tagged <italic>USP17N </italic>construct were incubated with hyaluronan or RNA and subjected to CPC precipitation. (A) Coprecipitated proteins were subjected to Western blot analysis with an antibody against the myc tag. CPC precipitation without the addition of CPC or myc-tagged <italic>USP17 </italic>construct was used as negative controls (lanes 1&#x02013;3). Without the addition of CPC, the whole cell lysate from cells transfected with myc-tagged <italic>USP17L </italic>or myc-tagged <italic>USP17N </italic>was used as a positive control (lane 7). (B) For RNA binding assay, total RNA of HeLa cells instead of hyaluronan were added.</p></caption><graphic xlink:href="1471-2164-7-292-7"/></fig><fig position="float" id="F8"><label>Figure 8</label><caption><p>The localization of USP17L and USP17N in HeLa cells. pEGFP-C1 vector (A) or pDsRed-C1 vector (B) transfected into HeLa cells was used as controls. In addition, GFP-tagged USP17L (C) or RFP-tagged USP17N (D) transfected into HeLa cells was used as controls. (E-G) HeLa cells co-transfected with GFP-tagged USP17L and RFP-tagged USP17N are shown with lower magnification (E-G) and with higher magnification (H-J). GFP-tagged USP17L proteins are highly condensed at the nucleoli in the nucleus (H: marked by arrows). RFP-tagged USP17N proteins are present both in the nucleus and cytoplasm (I: marked by arrows). GFP-tagged USP17L and RFP-tagged USP17N were combined in HeLa cells (G and J).</p></caption><graphic xlink:href="1471-2164-7-292-8"/></fig><fig position="float" id="F9"><label>Figure 9</label><caption><p>The effect of <italic>USP17 </italic>expression in HeLa cells. Overexpression of <italic>USP17L</italic>-induced apoptosis of cervical cancer cells. Either <italic>USP17L </italic>(C89S) or <italic>USP17N </italic>did not induce apoptosis.</p></caption><graphic xlink:href="1471-2164-7-292-9"/></fig><fig position="float" id="F10"><label>Figure 10</label><caption><p>The effect of <italic>USP17 </italic>expression in HeLa cells. Relative amounts of <italic>caspase 3 </italic>produced by real-time PCR. The amount of <italic>caspase 3 </italic>DNA in the control group was calibrated as 100 and relative amounts of <italic>caspase 3 </italic>DNA in cells transfected with either <italic>USP17L</italic>, <italic>USP17L </italic>(C89S) or <italic>USP17N </italic>were determined.</p></caption><graphic xlink:href="1471-2164-7-292-10"/></fig><fig position="float" id="F11"><label>Figure 11</label><caption><p>(A) FACS analysis. Cells expressing <italic>USP17L</italic>, <italic>USP17L </italic>(C89S), or <italic>USP17N </italic>were harvested 1 week apart for 3 weeks, fixed with ethanol, and stained with annexin V and PI. (B) The graph shows the ratio of cells in early (annexin V +, PI -) and late (annexin V +, PI +) stage apoptosis. The ratio of HeLa cells was calibrated as 100%.</p></caption><graphic xlink:href="1471-2164-7-292-11"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Percent amino acid identity among USP17 subfamily and DUB subfamily members.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">USP17A</td><td align="center">USP17B</td><td align="center">USP17C</td><td align="center">USP17D</td><td align="center">USP17F</td><td align="center">USP17G</td><td align="center">USP17H</td><td align="center">USP17I</td><td align="center">USP17J</td><td align="center">USP17</td><td align="center">DUB-3</td><td align="center">USP17K</td><td align="center">USP17L</td><td align="center">USP17M</td><td align="center">USP17N</td><td></td></tr></thead><tbody><tr><td align="center">100.0</td><td align="center">94.0</td><td align="center">98.5</td><td align="center">99.5</td><td align="center">93.6</td><td align="center">94.3</td><td align="center">100.0</td><td align="center">100.0</td><td align="center">100.0</td><td align="center">97.0</td><td align="center">99.3</td><td align="center">99.2</td><td align="center">98.3</td><td align="center">99.2</td><td align="center">98.5</td><td align="center">USP17A</td></tr><tr><td></td><td align="center">100.0</td><td align="center">94.0</td><td align="center">94.5</td><td align="center">99.2</td><td align="center">93.4</td><td align="center">94.0</td><td align="center">94.0</td><td align="center">94.0</td><td align="center">96.2</td><td align="center">94.7</td><td align="center">94.3</td><td align="center">93.4</td><td align="center">94.0</td><td align="center">94.0</td><td align="center">USP17B</td></tr><tr><td></td><td></td><td align="center">100.0</td><td align="center">99.2</td><td align="center">93.5</td><td align="center">40.4</td><td align="center">98.5</td><td align="center">98.5</td><td align="center">98.5</td><td align="center">95.7</td><td align="center">99.0</td><td align="center">98.7</td><td align="center">99.0</td><td align="center">98.2</td><td align="center">100.0</td><td align="center">USP17C</td></tr><tr><td></td><td></td><td></td><td align="center">100.0</td><td align="center">94.0</td><td align="center">40.8</td><td align="center">99.5</td><td align="center">99.5</td><td align="center">99.5</td><td align="center">96.2</td><td align="center">99.5</td><td align="center">99.2</td><td align="center">98.5</td><td align="center">98.7</td><td align="center">99.2</td><td align="center">USP17D</td></tr><tr><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">92.5</td><td align="center">93.6</td><td align="center">93.6</td><td align="center">93.6</td><td align="center">95.8</td><td align="center">94.2</td><td align="center">94.0</td><td align="center">93.0</td><td align="center">94.0</td><td align="center">93.5</td><td align="center">USP17F</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">94.3</td><td align="center">94.3</td><td align="center">94.3</td><td align="center">95.2</td><td align="center">47.4</td><td align="center">95.2</td><td align="center">93.0</td><td align="center">93.9</td><td align="center">40.4</td><td align="center">USP17G</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">100.0</td><td align="center">100.0</td><td align="center">97.0</td><td align="center">99.3</td><td align="center">99.2</td><td align="center">98.3</td><td align="center">99.2</td><td align="center">98.5</td><td align="center">USP17H</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">100.0</td><td align="center">97.0</td><td align="center">99.3</td><td align="center">99.2</td><td align="center">98.3</td><td align="center">99.2</td><td align="center">98.5</td><td align="center">USP17I</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">97.0</td><td align="center">99.3</td><td align="center">99.2</td><td align="center">98.3</td><td align="center">99.2</td><td align="center">98.5</td><td align="center">USP17J</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">96.6</td><td align="center">97.4</td><td align="center">96.4</td><td align="center">97.0</td><td align="center">95.7</td><td align="center">USP17</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">99.5</td><td align="center">98.8</td><td align="center">99.0</td><td align="center">99.0</td><td align="center">DUB-3</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">98.7</td><td align="center">99.2</td><td align="center">98.7</td><td align="center">USP17K</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">98.3</td><td align="center">99.0</td><td align="center">USP17L</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">98.2</td><td align="center">USP17M</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td align="center">100.0</td><td align="center">USP17N</td></tr></tbody></table></table-wrap></sec></back></article> 